Trump Says Israel And Iran Agree To Ceasefire To End '12 Day War'
In a statement on Truth Social, Trump said the ceasefire would take effect after both countries“have wound down and completed their in progress, final missions!”
According to the statement, the ceasefire would be implemented in stages.“Officially, Iran will start the CEASEFIRE and, upon the 12th Hour, Israel will start the CEASEFIRE and, upon the 24th Hour, an Official END to THE 12 DAY WAR will be saluted by the World,” the statement read. It added that during each side's ceasefire period,“the other side will remain PEACEFUL and RESPECTFUL.”
Trump expressed confidence in the agreement, stating,“On the assumption that everything works as it should, which it will, I would like to congratulate both Countries, Israel and Iran, on having the Stamina, Courage, and Intelligence to end” the conflict.
He added:“This is a War that could have gone on for years, and destroyed the entire Middle East, but it didn't, and never will!”
The statement concluded with the words:“God bless Israel, God bless Iran, God bless the Middle East, God bless the United States of America, and GOD BLESS THE WORLD!”
The statement was signed,“DONALD J. TRUMP, PRESIDENT OF THE UNITED STATES OF AMERICA”.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- 1Inch Becomes First Swap Provider Relaunched On OKX Wallet
- Ecosync & Carboncore Launch Full Stages Refi Infrastructure Linking Carbon Credits With Web3
- Leverage Shares Launches First 3X Single-Stock Etps On HOOD, HIMS, UNH And Others
- GCL Subsidiary, 2Game Digital, Partners With Kucoin Pay To Accept Secure Crypto Payments In Real Time
- Kintsu Launches Shype On Hyperliquid
- PLPC-DBTM: Non-Cellular Oncology Immunotherapy With STIPNAM Traceability, Entering A Global Acquisition Window.
Comments
No comment